Cambiar Investors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,665
| Closed | -$6.12M | – | 153 |
|
|
2025
Q1 | $6.12M | Buy |
40,665
+615
| +2% | +$92.6K | 0.26% | 90 |
|
|
2024
Q4 | $7.39M | Sell |
40,050
-5,880
| -13% | -$1.09M | 0.29% | 87 |
|
|
2024
Q3 | $9.05M | Buy |
45,930
+494
| +1% | +$97.3K | 0.35% | 85 |
|
|
2024
Q2 | $9.39M | Buy |
45,436
+316
| +0.7% | +$65.3K | 0.37% | 84 |
|
|
2024
Q1 | $12.2M | Sell |
45,120
-15,093
| -25% | -$4.09M | 0.46% | 74 |
|
|
2023
Q4 | $14.2M | Buy |
60,213
+9,651
| +19% | +$2.28M | 0.56% | 56 |
|
|
2023
Q3 | $9.91M | Buy |
50,562
+1,811
| +4% | +$355K | 0.42% | 79 |
|
|
2023
Q2 | $10.2M | Buy |
48,751
+5,664
| +13% | +$1.19M | 0.43% | 76 |
|
|
2023
Q1 | $8.7M | Buy |
43,087
+8,607
| +25% | +$1.74M | 0.37% | 81 |
|
|
2022
Q4 | $7.51M | Buy |
34,480
+2,387
| +7% | +$520K | 0.34% | 83 |
|
|
2022
Q3 | $6.32M | Buy |
32,093
+948
| +3% | +$187K | 0.32% | 81 |
|
|
2022
Q2 | $6.66M | Sell |
31,145
-355
| -1% | -$76K | 0.3% | 82 |
|
|
2022
Q1 | $8.95M | Buy |
+31,500
| New | +$8.95M | 0.34% | 74 |
|
|
2021
Q2 | – | Sell |
-22,661
| Closed | -$6.57M | – | 149 |
|
|
2021
Q1 | $6.57M | Buy |
22,661
+2,919
| +15% | +$846K | 0.23% | 89 |
|
|
2020
Q4 | $4.93M | Sell |
19,742
-4,537
| -19% | -$1.13M | 0.19% | 86 |
|
|
2020
Q3 | $5.5M | Sell |
24,279
-3,076
| -11% | -$697K | 0.25% | 68 |
|
|
2020
Q2 | $4.77M | Sell |
27,355
-5,110
| -16% | -$891K | 0.22% | 72 |
|
|
2020
Q1 | $4.1M | Buy |
+32,465
| New | +$4.1M | 0.21% | 67 |
|